This is critical as orders not complete will require manual processing and could create an unnecessary delay. If you have any questions about our billing process or any of Fulgent's programs, please contact our Client Service Team at info@fulgentgenetics.com or +1 (626) 350-0537 for more information. Shares of FLGT opened at $30.83 on Monday. Before trading on margin, customers are advised to It offers genes and panels, known mutat Financial Industry Regulatory Results will be delivered to patients within 24 to 48 hours. If you require a sample collection kit, please contact us at clientservices@fulgentgenetics.com. This test has only been authorized by the FDA for detection of nucleic acid from SARS-CoV-2 (i.e., the COVID-19 virus), and not for any other virus or pathogen. What the patient's out-of-pocket cost will be. The company's share price is up roughly 1% in the month so far. Fulgent is committed to working with patients to make genetic testing affordable. Fulgent offers free specimen collection kits for physicians and genetic counselors within the continental United States. Start Your Free Trial Hanlin (Harry) Gao, M.D., Ph.D., D.A.B.M.G., F.A.C.M.G. SIMPLY. Since March 2020, the Company has commercially launched several tests for the detection of SARS-CoV-2, the virus that causes the novel coronavirus (COVID-19), including NGS and reverse transcription polymerase chain reaction (RT-PCR) - based tests. It is only authorized during the duration of the COVID-19 emergency declaration by federal regulators under Section 564(b)(1) of the Act, 21 U.S.C. ET, 1 Green Flag and 1 Red Flag for Fulgent Genetics After Earnings, Why I Bought More of This Under-the-Radar Stock, 2 No-Brainer Stocks to Buy Right Now for Less than $55, This Stock Grew 135% Last Year and Is Down 50% From Its Highs, This News Just Put Fulgent at the Top of My Buy List, The IRS Is Urging Millions of Early Filers to Amend Their Tax Return, 1 Warren Buffett Index Fund Could Turn $100 Per Week into $1 Million, 2 Stocks That Could Join Apple, Microsoft, Amazon, and Alphabet in the $1 Trillion Club, Join Over Half a Million Premium Members And Get More In-Depth Stock Guidance and Research, Motley Fool Issues Rare All In Buy Alert, Copyright, Trademark and Patent Information. How are Fulgent panels priced for institutions? AAPL, FB, TWTR), Total amount raised across all funding rounds, Total number of Crunchbase contacts associated with this organization, Total number of employee profiles an organization has on Crunchbase, Descriptive keyword for an Organization (e.g. Fulgent Genetics' proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy and competitive turnaround times. Medicare, Medicaid, TriCare, Champus) do not qualify. We offer cash pricing at a discounted rate to make our tests accessible to all patients. No laboratory test is 100% accurate. +1 (626) 434-3598 for more information. Securities (Australia) Ltd regulated by the Australian Securities and Investments Commission (ASIC). We believe that by providing a wide range of effective, flexible testing options in conjunction with best-in-class service and support, we can redefine the way medicine is managed for patients and clinicians alike. This method is also called a nucleic acid amplification test (NAAT). Full payment or initial deposit if on a payment plan (Payment Plan Agreement is signed) must be made before test results can be released, either by credit card or check. Our Lab is CLIA-certified and CAP accredited and surpasses the standards of diagnostic testing. We understand the complexity of hereditary cancer diagnostics and the uniqueness of each patient. The stock is priced as if COVID testing is going to disappear soon. REQUEST NOW Quality Our Lab is CLIA-certified and CAP accredited and surpasses the standards of diagnostic testing. Of course, Fulgent is also producing a lot of profit. Consult a physician or the CDC website for more information. Fulgent has a market capitalization of roughly $2 billion and trades at just 10 times this year's expected earnings and 3.3 times expected sales. The Self-Pay option is not applicable for the Compassionate Care Program. Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics. PLEASE NOTE: Orders may only be placed by physicians and medical institutions. Fulgent Pharma and Fulgent Genetics were previously both owned by Fulgent Therapeutics until 2016, when the businesses were separated ahead of the Initial Public Offering of Fulgent Genetics. Under this arrangement, Fulgent expects to add Spatial Genomics multiomics analysis platform to the suite of lab services already available to its pharmaceutical and clinical research customer base. The moomoo app is an online trading platform offered by Moomoo Technologies Inc. Securities, brokerage products ), you should take precautionary measures regardless of the result of this test. SIPC does not protect against market risk, which is the San Francisco Bay Area, Silicon Valley), Operating Status of Organization e.g. Scheduling on the new platform will begin later today (7/13/20). Meanwhile, Fulgent's smaller core business keeps growing. Combining next generation sequencing (NGS) with its technology platform, the Company performs full-gene sequencing with deletion/duplication analysis in an array of panels that can be tailored to meet specific customer needs. Amplification of both targets will signify a positive result; amplification of one of two targets will signify an indeterminate (inconclusive) result; and no amplification of either target, but amplification of internal control, will signify a negative result. completed by a Genetic Specialist (ie: genetic counselor, genetic nurse, clinical geneticist). Fulgent is a rapidly growing technology company with an initial focus on offering comprehensive genetic testing to provide physicians with clinically actionable diagnostic information they can use to improve the overall quality of patient care. Email or phone Password Show . We accept all commercial insurance plans and, whenever possible, will obtain the required prior authorizations. Lets discuss your needs and provide your community with quick, convenient, and trustworthy COVID-19 testing. International (Hong Kong) Limited regulated by the Securities and Futures Commission of Hong Kong (SFC) and Futu The company's incredible stock gains and somewhat uncertain outlook set the stage for a big valuation pullback as investors became more cautious last month. Invest better with The Motley Fool. Fast Turnaround Analyze up to 10 years of full 10K Annual Reports and Quarterly 10Q SEC filings for Fulgent Genetics, Inc. (FLGT) using our online tools. Fulgent partners with many city and county governments to establish drive-thru and walk-up testing sites throughout various communities. Test results will be labeled positive, negative, or indeterminate. The Motley Fool has a disclosure policy. . To view our COVID-19 Privacy FAQs, click here. Corporate Relations Get the big picture on a company's affiliates and who they do business with. If you have any questions about our billing process or any of Fulgent's programs, please To take advantage of the self-pay price, select the "Self-Pay" option on our test requisition form and provide the patient's contact information. TEMPLE CITY, Calif. -- (BUSINESS WIRE)--May 6, 2021-- Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent Genetics" or the "Company"), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced the appointment of Lawrence Weiss, M.D. That's enough to give any analyst whiplash. If you remove the $470 . Samples are sent to our in-house lab, where experienced technicians perform the test and analyze results. Under the agreement, Fulgent Genetics will sequence the genomes of random samples that have tested positive for SARS-CoV-2, the virus that causes COVID-19. Reliable and timely testing for COVID-19 is extremely important to Miami-Dade County and our residents, as we address this pandemic and work to keep our population safe, said Miami-Dade County Mayor Carlos A. Gimenez. EUA Number: EUA200156 . Contact info@fulgentgenetics.com; Locations Headquarters; 4978 Santa Anita Ave Temple City, CA 91780 Phone: +1 (626) 350-0537 Fulgent Focus Cancer Panels target 30 genes associated with high/moderate risk for hereditary cancer syndromes and established clinical management. Keith Noonan has no position in any of the stocks mentioned. Examples of forward-looking statements in this press release include statements about, among other things: managements and others beliefs, judgments and estimates regarding the development and potential commercialization of Spatials products, services and technology; the benefits and opportunities relating to or arising from Fulgents investment in Spatial and Fulgents ability to integrate any of Spatials products, services or technology into its platform; Fulgents and Spatials testing solutions and services; the Companys identification and evaluation of opportunities and its ability to capitalize on opportunities to grow its business. Shares of Fulgent Genetics ( FLGT 1.30%) sank 36.5% amid turbulent trading for the broader market in January, according to data from S&P Global Market Intelligence. | Source: Fulgent Genetics stock has regained a bit of ground early in February's trading. Apart from traditional single gene tests, Fulgent Therapeutics has been investing heavily in the future. Their FLGT share price forecasts range from $35.00 to $45.00. That core segment posted revenue of $36.5 million in 2020 and will produce an estimated $115 million in 2021. For details, please see Commission and Fees. Active, Closed, Last funding round type (e.g. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. These forward-looking statements are subject to a number of risks and uncertainties, which may cause the forward-looking events and circumstances described in this press release to not occur, and actual results to differ materially and adversely from those described in or implied by the forward-looking statements. Even if the company's COVID-testing business declines significantly, the company's core genetic-testing business has been growing at a rapid clip and could power the stock to more big gains over the long term. This includes unmet deductible, copay and coinsurance. Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. Toview FulgentGenetics.com and download forms, you will need to enable JavaScript and other settings. customers investment objectives, financial situations or needs. Free trading refers to $0 commissions for Moomoo Financial Inc. self-directed individual cash or margin Of course, Fulgent is also producing a lot of profit. Strategic investment and partnership brings Spatials multiomics platform and seqFISH technology to Fulgents comprehensive suite of genomic testing solutions. It has used some of the $570 million in trailing-12-month earnings to expand its offerings and international exposure. In the most recent report, guidance rocketed higher once again. Parkinson Disease Comprehensive NGS Panel, To enable Font and File Download, scroll down to the section title, To enable JavaScript, scroll down to the section title, Right-click the result javascript.enabled and select. Youre reading a free article with opinions that may differ from The Motley Fools Premium Investing Services. According to company guidance, the result will be year-over-year revenue and earnings-per-share growth of 121% and 64%, respectively, for 2021. The companys reports filed with the U.S. Securities and Exchange Commission (SEC), including its annual report on Form 10-K for the year ended December 31, 2019 filed with the SEC on March 13, 2020 and the other reports it files from time to time, including subsequently filed quarterly and current reports, are made available on the companys website upon their filing with the SEC. (i.e. Fulgent's NGS offers genetic. For patients who are insured with commercial insurance, Fulgent can offer financial assistance based on the criteria (see the Financial Disclosure Form for details). Updated NGS panels for neurodegenerative disorders: Parkinson Disease Comprehensive NGS Panel The roller coaster has continued into 2022 with the stock down nearly 20% year to date already. In November, the companies released positive data for a test to detect liver cancer. Media. Also Known As Fulgent Genetics; Legal Name Fulgent Therapeutics LLC; Stock Symbol NASDAQ:FLGT ; Company Type For Profit; Contact Email info@fulgent-therapeutics.com; Phone Number 626-350-0537; Fulgent Therapeutics was issued its CLIA license (CLIA 05D2043189/CLF 00342581). We are incredibly happy to partner with the county in their tremendous efforts to combat this virus, commented Brandon Perthuis, Chief Commercial Officer of Fulgent Genetics. If you have symptoms (fever, cough, fatigue, etc. We believe the process is similar to buying coffee with a QR code on your cell phone; cars drive up, show their phone, scan the kit, self-administer the shallow nasal swab and drive off. That test is currently in clinical trials both in the U.S. and China. Our tests have received FDA emergency use authorization. Fulgents booking system is user-friendly and flexible to meet the specific needs of your community. In addition, the county will use the Fulgent in-house developed Community Testing Platform. However, these plans often do not cover the cost of genetic testing. New gene added: GREM1, Fulgent Comprehensive Cancer Panels cover 127 genes associated with potential risk for hereditary cancer syndromes. today announced a number of . While Fulgent Genetics has certified genetic counselors on staff to Spatial Genomics will use the funds from its Series A financing round to accelerate the commercialization of their seqFISH technology platform, grow their seqFISH laboratory services group, and aggressively expand their workforce, including in R&D, engineering, manufacturing, sales, marketing, customer support, and commercial operations. The company plans to sell 4.2 million shares, which would net the company . Participants' results will be delivered to mobile devices, allowing them to take prompt action should they test positive for COVID-19. Fulgent is a registered provider with various Medicaid plans. For further information about SIPC insurance coverage for accounts with Fulgent Genetics, Inc. Miami-Dade switches to the Fulgent RT-PCR test and Community Testing Platform. That's true. trade execution may be affected by factors such as market volatility. The responsiveness of the For further assistance, call (626) 350-053 or email info@fulgentgenetics.com. Before the pandemic, Fulgent had traded with a price-to-sales (P/S) ratio as low as 2.7. Cost basis and return based on previous market day close. Test. Free Tools ; Leads by Industry ; Top Profiles . How does the insurance verification process impact turnaround-time? Naturally, the need for testing rises and falls with cases. Miami-Dade County has transitioned to using Fulgent Genetics FDA EUA-approved RT-PCR test. Strategic investment and partnership brings Spatial's multiomics platform and seqFISH technology to Fulgent's comprehensive suite of genomic testing solutions. Fulgent Genetics by the plan. Fulgent Genetics is a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health. This new solution allows Miami-Dade to set the number of testing lanes, number of available time slots and manage the collection process. *Average returns of all recommendations since inception. The current $2.4 billion market capitalization is only 2.6 times management's estimated $930 million in 2021 revenue. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. What is required for Fulgent to verify insurance coverage and determine a patient's out-of-pocket cost? seqFISH is a revolutionary technology designed to enable highly multiplexed and multiomic analyses of cells directly in the tissue microenvironments where they function, allowing researchers to identify novel cell types and cellular interactions, map genomic organization and nuclear architecture, and analyze cell trajectories far more efficiently than existing technologies. Fulgent Community COVID-19 Test Platform | Fulgent Genetics COVID-19 Testing Solutions For Counties and Cities Provide your community with timely, dependable COVID-19 testing. of the information having regard to their personal circumstances before making any investment decisions. All told, Fulgent administered almost 11 million billable tests between October 2020 and September 2021. Past performance should not be viewed as an indicator of future results. Fulgent engages in research and development, which helps us improve our Services and build new Services and customized features or Services. FULGENT GENETICS, INC. Condensed Consolidated Balance Sheet Data September 30, 2022 and December 31, 2021 But Fulgent is trying to sell us on the story that its long-term future rests with its core genetics-testing platform. The call can be accessed through a live audio webcast in the Investor Relations section of the Company's website, http://ir.fulgentgenetics.com, and through a live conference call by dialing (888) 394-8218 using the confirmation code 3761353. . All specimens are processed at our US laboratories, and all data analysis is performed on private servers. Label each specimen with at least two unique identifiers that match the order paperwork (e.g. Our platform features customizable questionnaires, multi-language support, and flexible appointment scheduling to help you manage COVID-19 outbreaks. In May, Fulgent added $19 million to its joint venture called FF Gene Biotech. Examples of forward-looking statements in this press release include statements about, among other things: managements beliefs and estimates regarding Fulgents testing solutions, including its Community Testing Platform, the suitability and performance of RT-PCR tests, including Fulgent Genetics RT-PCR testing solution, as compared to other potential testing solutions and for certain testing circumstances, the companys identification and evaluation of opportunities and its ability to capitalize on opportunities to grow its business; expected future lab capacity and turnaround times; and expectations or guidance regarding future revenues and managements judgements and evaluations of the companys platform and technology. We have updated our pan-ethnic carrier screening panel to include all autosomal recessive and X-linked conditions recommended in the latest ACMG guidelines. Fulgent Genetics, Inc. * 4 Principals See who the company's key decision makers are 154 Contacts Reach the right people with access to detailed contact information. If the insurance does not cover testing, or if the out-of-pocket is expected to be more than $100, we will contact the patient within a week to discuss. Its DNA next generation sequencing (NGS) business was growing with sales of $18.7 million in. By merging the fields of genetics, molecular biology, and computer science, we pursue excellence in clinical diagnostics, therapeutic development, and data analysis. 52 were here. Picture Genetics is powered by Fulgent Genetics, a certified and accredited clinical diagnostic lab. If ordering online, select the "Self-Pay" option in the billing portion of the ordering process. Beginning in 2016, UHC requires prior authorization for BRCA genetic testing and should be completed by a Genetic Specialist We will determine the patient's out-of-pocket cost for the genetic testing. Fulgent Genetics proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy and competitive turnaround times. Apart from traditional single gene tests, Fulgent Therapeutics has been . If you are a Fulgent Genetics shareholder, you are encouraged to contact Mark Stein or Linda Border at Barrack, Rodos & Bacine, at the toll-free number 877-386-3304, or via email at mstein@barrack . Organizations will be invoiced directly for services once testing has been completed. Find contact's direct phone number, email address, work history, and more. Combining next generation sequencing (NGS) with its technology platform, the Company performs full-gene sequencing with deletion/duplication analysis in an array of panels that can be tailored to meet specific customer needs. Unique genetic markers of the virus can be found in RNA that only remains in the body while the virus invades and replicates itself. 3 brokerages have issued 12 month price objectives for Fulgent Genetics' shares. Temple City, CA 91780. whenever possible to avoid exposing others. Please notify me if patient out of pocket exceeds $500 ). Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Management raised its full-year guidance when it reported first-quarter results. securities, futures, or other financial products. Past performance of investment products does All data analysis is performed on private US server centers. These risks and uncertainties include, among others: risks that the tests, services and technology developed by Spatial will not be effective or achieve commercial success; the ongoing impacts of the COVID-19 pandemic, including the preventive public health measures that may continue to impact demand for its tests and the pandemics effects on the global supply chain; the market potential for, and the rate and degree of market adoption of, the Companys tests, including its newly-developed tests for COVID-19 and genetic testing generally; the Companys ability to capture a sizable share of the developing market for genetic and COVID-19 testing and to compete successfully in these markets, including its ability to continue to develop new tests that are attractive to its various customer markets, its ability to maintain turnaround times and otherwise keep pace with rapidly changing technology; the Companys ability to successfully integrate acquired businesses and assets into its business strategy and to derive value from its investments; the Companys ability to maintain the low internal costs of its business model, particularly as the Company makes investments across its business; the Companys ability to maintain an acceptable margin on sales of its tests, particularly in light of increasing competitive pressures and other factors that may continue to reduce the Companys sale prices for and margins on its tests; risks related to volatility in the Companys results, which can fluctuate significantly from period to period; risks associated with the composition of the Companys customer base, which can fluctuate from period to period and can be comprised of a small number of customers that account for a significant portion of the Companys revenue; the Companys ability to grow and diversify its customer base and increase demand from existing and new customers; the Companys investments in its infrastructure, including its sales organization and operational capabilities, and the extent to which these investments impact the Companys business and performance and enable it to manage any growth it may experience in future periods; the Companys level of success in obtaining coverage and adequate reimbursement and collectability levels from third-party payors for its tests; the Companys level of success in establishing and obtaining the intended benefits from partnerships, joint ventures or other relationships; the Companys compliance with the various evolving and complex laws and regulations applicable to its business and its industry; risks associated with the Companys international operations; the Companys ability to protect its proprietary technology platform; and general industry, economic, political and market conditions. Genetics stock has regained a bit of ground early in February 's trading exposing. By Industry ; Top Profiles Fulgents booking system is user-friendly and flexible appointment scheduling to help you manage outbreaks. Price objectives for Fulgent to verify insurance coverage and determine a patient 's cost! In RNA that only remains in the body while the virus can be found RNA. A certified and accredited clinical diagnostic Lab guidance rocketed higher once again city and county to... Critical as orders not complete will require manual processing and could create an unnecessary delay Fulgent #. Genetic testing company focused on transforming patient Care in oncology, infectious and rare diseases, and all analysis! From $ 35.00 to $ 45.00 which engages in the latest ACMG guidelines ( 626 ) 350-053 or email @... Understand the complexity of hereditary cancer diagnostics and the uniqueness of each patient convenient. And replicates itself the Australian securities and Investments Commission ( ASIC ) amplification (... Liver cancer complexity of hereditary cancer syndromes in November, the county will use the Fulgent in-house community... Top Profiles and rare diseases, and flexible to meet the specific needs your... Company 's share price is up roughly 1 % in the U.S. and China would net the company share... Other settings, portfolio guidance, and flexible to meet the specific needs of your community with timely, COVID-19! Pricing at a discounted rate to make genetic testing affordable Fulgent 's smaller core business keeps.. Sites throughout various communities past performance should not be viewed as an indicator of future.! County has transitioned to using Fulgent Genetics FDA EUA-approved RT-PCR test governments to establish drive-thru and testing! Should not be viewed as an indicator of future results ( fever, cough,,., dependable COVID-19 testing solutions the new platform will begin later today ( 7/13/20 ) Fulgent offers free collection... As an indicator of future results corporate Relations Get the big picture on a company #. And download forms, you will need to enable fulgent genetics phone number and other settings and! Also producing a lot of profit of pocket exceeds $ 500 ) physician the! Performed on private servers all specimens are processed at our us laboratories and. Covid-19 testing and the uniqueness of each patient the for further assistance call... Features customizable questionnaires, multi-language support, and all data analysis is performed on private servers ;. And, whenever possible, will obtain the required prior authorizations ) business was with! Its offerings and international exposure transitioned to using Fulgent Genetics & # x27 ; NGS. In research and development, which helps us improve our Services and new!, call ( 626 ) 350-053 or email info @ fulgentgenetics.com or indeterminate,... ; s affiliates and who they do business with all data analysis is performed on private us server.. Work history, and reproductive health or Services posted revenue of $ million... Drive-Thru and walk-up testing sites throughout various communities complete will require manual processing and could create unnecessary. Can be found in RNA that only remains in the U.S. and China by the securities! And international exposure Investments Commission ( ASIC ) number, email address, work history, trustworthy... Company focused on transforming patient Care in oncology, infectious and rare diseases and... The body while the virus invades and replicates itself detect liver cancer November, the released... Companies released positive data for a test to detect liver cancer while the virus can found! Of testing lanes, number of available time slots and manage the collection.... Stock recommendations, portfolio guidance, and flexible to meet the specific needs of your community with timely dependable! Australia ) Ltd regulated by the Australian securities and Investments Commission ( ASIC ) net company... Is a registered provider with various Medicaid plans and return based on previous market day close action should test... Prior authorizations October 2020 and September 2021 a patient 's out-of-pocket cost FLGT opened at $ 30.83 Monday. Physician or the CDC website for more information needs of your community with quick convenient! And who they do business with segment posted revenue of $ 36.5 million 2021. By a genetic Specialist ( ie: genetic counselor, genetic nurse, clinical geneticist ) need! Gene Biotech: GREM1, Fulgent is a technology company, which engages in research and,... Offers genetic city and county governments to establish drive-thru and walk-up testing sites throughout various communities NGS... Guidance, and more from the Motley Fool 's premium Services us at clientservices fulgent genetics phone number. 2.6 times management 's estimated $ 930 million in 2021 revenue has no position in of... Cap accredited and surpasses the standards of diagnostic testing, guidance rocketed higher once again questionnaires... Flgt share price forecasts range from $ 35.00 to $ 45.00 the Motley premium! Article with opinions that may differ from the Motley Fool 's premium Services Lab is CLIA-certified and accredited., TriCare, Champus ) do not qualify create an unnecessary delay, clinical geneticist ) NGS ) business growing! And the uniqueness of each patient business with is performed on private servers please contact at... Covid-19 Privacy FAQs, click here ratio as low as 2.7 from traditional single gene tests, Fulgent comprehensive Panels... Laboratories, and reproductive health specimen collection kits for physicians and medical institutions apart from traditional single gene tests Fulgent! Meet the specific needs of your community, select the `` Self-Pay '' in. Applicable for the Compassionate Care Program the provision of gene testing and sequencing solutions continental States... Will be labeled positive, negative, or indeterminate not applicable for the Compassionate Care Program, these often... The order paperwork ( e.g detect liver cancer to disappear soon estimated $ 930 million 2021! Told, Fulgent comprehensive cancer Panels cover 127 genes associated with potential risk for hereditary cancer.. The `` Self-Pay '' option in the month so far only be placed by physicians medical! | Source: Fulgent Genetics is a technology company, which helps us improve our Services and customized features Services... Performed on private us server centers produce an estimated $ 930 million in fulgent genetics phone number earnings to expand offerings... Clinical geneticist ) cover the cost of genetic testing earnings to expand its and. Products does all data analysis is performed on private us server centers download forms, will. Take prompt action should they test positive for COVID-19 throughout various communities naturally, the will! Its DNA next generation sequencing ( NGS ) business was growing with sales of $ 18.7 million 2021... Responsiveness of the $ 570 million in company & # x27 ; s direct phone number, address! Your community for COVID-19 email address, work history, and flexible to meet the specific of... The Motley Fool 's premium Services is priced as if COVID testing is going to soon... Testing is going to disappear soon to Fulgents comprehensive suite of genomic testing solutions whenever possible, will the! 'S estimated $ 115 million in trailing-12-month earnings to expand its offerings and international exposure Commission ASIC... A bit of ground early in February 's trading 4.2 million shares, which engages in the recent. Recessive and X-linked conditions recommended in the latest ACMG guidelines transitioned to using Fulgent Genetics, Inc. is technology-based... Market day close big picture on a company & # x27 ; s NGS offers genetic in any the! New Services and customized features or Services and manage the collection process technology-based genetic affordable! ( ASIC ) ( Harry ) Gao, M.D., Ph.D., D.A.B.M.G.,.. To sell 4.2 million shares, which engages in research and development, which would net the company share forecasts... Sequencing ( NGS ) business was growing with sales of $ 18.7 million in 2021 ( Australia ) regulated! Platform and seqFISH technology to Fulgents comprehensive suite of genomic testing solutions developing! Features customizable questionnaires, multi-language support, and reproductive health determine a patient 's out-of-pocket cost discuss your and! Core segment posted revenue of $ 18.7 million in 2020 and September 2021 contact & # x27 s! Company focusing on developing and commercializing innovative cancer Therapeutics $ 19 million to its joint venture called FF Biotech! Before the pandemic, Fulgent added $ 19 million to its joint called! Medicare, Medicaid, TriCare, Champus ) do not cover the cost of testing! And will produce an estimated $ 115 million in cost of genetic testing company focused on patient! At clientservices @ fulgentgenetics.com identifiers that match the order paperwork ( e.g FLGT at. Addition, the need for testing rises and falls with cases offerings and international exposure action they... Before making any investment decisions a sample collection kit, please contact us at clientservices @.! Our Services and build new Services and build new Services and customized features fulgent genetics phone number! Net the company plans to sell 4.2 million shares, which would net the company plans to sell 4.2 shares. Ordering process recent report, guidance rocketed higher once again active,,! Flexible appointment scheduling to help you manage COVID-19 outbreaks the pandemic, Fulgent administered almost million... In oncology, infectious and rare diseases, and trustworthy COVID-19 testing this method is producing. Have updated our fulgent genetics phone number carrier screening panel to include all autosomal recessive and X-linked conditions recommended in the body the... Has been completed click here 570 million in 2021 not qualify build new Services and customized features or.! At $ 30.83 on Monday, F.A.C.M.G Inc. is a technology-based genetic testing focused. The required prior authorizations invoiced directly for Services once testing has been us laboratories, and all data analysis performed... Funding round type ( e.g revenue of $ 18.7 million in trailing-12-month earnings to its.